Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Murphy CC, Zaki TA. Changing epidemiology of colorectal cancer - birth cohort effects and emerging risk factors. Nat Rev Gastroenterol Hepatol. 2024;21:25–34. https://doi.org/10.1038/s41575-023-00841-9.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network. Rectal Cancer. In: NCCN Clinical Practice Guidelines in Oncology. Version 2.2025. National Comprehensive Cancer Network. 2025. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1461. Accessed 10 May 2025.

Kasi A, Abbasi S, Handa S, et al. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3:e2030097. https://doi.org/10.1001/jamanetworkopen.2020.30097.

Article  PubMed  PubMed Central  Google Scholar 

Kagawa Y, Watanabe J, Uemura M, et al. Short-term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE-1). Ann Gastroenterol Surg. 2023;7:968–76. https://doi.org/10.1002/ags3.12715.

Article  PubMed  PubMed Central  Google Scholar 

Wo JY, Anker CJ, Ashman JB, et al. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021;11:13–25. https://doi.org/10.1016/j.prro.2020.08.004.

Article  PubMed  Google Scholar 

de Jong R, De Roover R, Devlin L, et al. ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer. Radiother Oncol. 2026;218:111409. https://doi.org/10.1016/j.radonc.2026.111409.

Article  PubMed  Google Scholar 

Wee CW, Kang HC, Wu HG, et al. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity. Jpn J Clin Oncol. 2018;48:458–66. https://doi.org/10.1093/jjco/hyy029.

Article  PubMed  Google Scholar 

Yang TJ, Oh JH, Son CH, et al. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res. 2013;6:129–36.

PubMed  PubMed Central  Google Scholar 

Hoffmann M, Waller K, Last A, Westhuyzen J. A critical literature review on the use of bellyboard devices to control small bowel dose for pelvic radiotherapy. Rep Pract Oncol Radiother. 2020;25:598–605. https://doi.org/10.1016/j.rpor.2020.04.019.

Article  PubMed  PubMed Central  Google Scholar 

Scobioala S, Kittel C, Niermann P, et al. A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma: Comparison of 3–dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy. Strahlenther Onkol. 2018;194:975–84. https://doi.org/10.1007/s00066-018-1324-0.

Article  PubMed  Google Scholar 

Joye I, Verstraete J, Bertoncini C, Depuydt T, Haustermans K. Implementation of volumetric modulated arc therapy for rectal cancer: Pitfalls and challenges. Acta Oncol. 2015;54:1677–81. https://doi.org/10.3109/0284186x.2015.1064159.

Article  PubMed  Google Scholar 

Rectal cancer. In. Japanese Society for Radiation Oncology (JASTRO), editor. JASTRO Guidelines 2024 for Radiotherapy Treatment Planning. 6th ed. Tokyo: Kanehara Shuppan; 2024. pp. 239–43.

Google Scholar 

Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74:824–30. https://doi.org/10.1016/j.ijrobp.2008.08.070.

Article  PubMed  Google Scholar 

Hong TS, Moughan J, Garofalo MC, et al. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015;93:29–36. https://doi.org/10.1016/j.ijrobp.2015.05.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3rd English Edition [Secondary Publication]. J Anus Rectum Colon. 2019;3(4):175–95. https://doi.org/10.23922/jarc.2019-018.

Article  Google Scholar 

Bentzen SM, Constine LS, Deasy JO, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3–9. https://doi.org/10.1016/j.ijrobp.2009.09.040.

Article  PubMed  PubMed Central  Google Scholar 

Robertson JM, Lockman D, Yan D, Wallace M. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70:413–8. https://doi.org/10.1016/j.ijrobp.2007.06.066.

Article  CAS  PubMed  Google Scholar 

Baglan KL, Frazier RC, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002;52:176–83. https://doi.org/10.1016/s0360-3016(01)01820-x.

Article  PubMed  Google Scholar 

Gunnlaugsson A, Kjellén E, Nilsson P, et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol. 2007;46:937–44. https://doi.org/10.1080/02841860701317873.

Article  CAS  PubMed  Google Scholar 

Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2013;85:1225–31. https://doi.org/10.1016/j.ijrobp.2012.09.036.

Article  PubMed  Google Scholar 

Lukovic J, Hosni A, Liu A, et al. Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer. Radiother Oncol. 2023;178:109429. https://doi.org/10.1016/j.radonc.2022.11.018.

Article  CAS  PubMed  Google Scholar 

Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol. 2003;69:201–7. https://doi.org/10.1016/j.radonc.2003.05.001.

Article  PubMed  Google Scholar 

Abraham AG, Usmani N, Warkentin B, et al. Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation. Pract Radiat Oncol. 2021;11:e70–9. https://doi.org/10.1016/j.prro.2020.07.004.

Article  PubMed  Google Scholar 

Guerrero Urbano T, Khoo V, Staffurth J, et al. Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol (R Coll Radiol). 2010;22:236–44. https://doi.org/10.1016/j.clon.2010.01.005.

Article  CAS  PubMed  Google Scholar 

Alvarez JA, Shi Q, Dasari A, et al. Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. BMC Cancer. 2024;24:901. https://doi.org/10.1186/s12885-024-12529-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang G, Wang W, Jin H, et al. Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity. Front Oncol. 2022;12:843704. https://doi.org/10.3389/fonc.2022.843704.

Article  PubMed  PubMed Central  Google Scholar 

Schrag D, Shi Q, Weiser MR, et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023;389:322–34. https://doi.org/10.1056/NEJMoa2303269.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60. https://doi.org/10.1016/j.ctro.2018.01.001.

Article  PubMed  PubMed Central  Google Scholar 

Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86:27–33. https://doi.org/10.1016/j.ij